Earnings Feed
Start Free
Home/Insiders/Kirson Eilon D.
KE
SEC Insider//CIK 0001654356

Kirson Eilon D.

CIK 00016543561 companyMALVERN, PA
SEC Profile

Transactions

50

Companies

1

Filings

6

CIK

0001654356

Recent Transactions

50 trades
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2019-02-27−6,945→ 13,888 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-02-27$52.90/sh+6,945→ 152,408 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-02-22$53.38/sh+36,400→ 145,463 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2019-02-22−36,400→ 36,399 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2019-01-17−68,813→ 66,522 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-01-17$45.25/sh−68,813→ 109,063 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-01-17$14.37/sh+68,813→ 177,876 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-01-16$45.11/sh−100,000→ 109,063 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2019-01-16−100,000→ 135,335 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-01-16$14.37/sh+100,000→ 209,063 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-07-06$17.25/sh+1,231→ 109,063 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2018-06-13+30,750→ 235,335 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-06-13$11.46/sh+37,500→ 107,832 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2018-06-13+37,500→ 37,500 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-06-13$14.37/sh+30,750→ 70,332 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-06-04$7.48/sh+59,130→ 92,197 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-06-04$7.03/sh+218,781→ 258,363 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-06-04$28.60/sh−225,296→ 33,067 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-06-04$7.15/sh+68,250→ 160,447 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-06-04$30.26/sh−1,800→ 43,713 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-06-04$31.74/sh−4,131→ 39,582 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2018-06-04+218,781→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-06-04$29.36/sh−114,934→ 45,513 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2018-06-04+59,130→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2018-06-04+68,250→ 204,750 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2018-04-18+70,956→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-04-18$3.44/sh+70,956→ 110,538 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-04-18$3.44/sh+76,869→ 116,451 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-04-18$24.00/sh−76,869→ 39,582 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2018-04-18+76,869→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-04-18$24.00/sh−70,956→ 39,582 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2018-02-27+152,068→ 152,068 total
  • Award
    NovoCure Ltd$NVCR

    Restricted Stock Unit

    2018-02-27+20,833→ 20,833 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-02-22$21.55/sh+36,401→ 39,582 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2018-02-22+36,401→ 72,799 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2018-01-11$22.00/sh−25,320→ 3,181 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-11-06$22.00/sh−9,100→ 28,501 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-11-03$22.00/sh−3,100→ 37,601 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-11-02$22.00/sh−300→ 40,701 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-11-01$22.01/sh−22,119→ 41,001 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-10-31$22.00/sh−150→ 63,120 total
  • Disposition to Issuer
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-09-25$22.03/sh−1,900→ 63,270 total
  • Disposition to Issuer
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-09-14$22.03/sh−2,500→ 65,170 total
  • Disposition to Issuer
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-09-13$22.01/sh−46,872→ 67,670 total
  • Disposition to Issuer
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-07-05$18.14/sh−111,361→ 114,542 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-07-05$6.67/sh+3,181→ 225,903 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-06-21$16.77/sh−66,361→ 222,722 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-06-19$15.06/sh−15,000→ 289,083 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-06-13$15.01/sh−9,044→ 304,083 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2017-06-12$15.08/sh−5,956→ 313,127 total

Companies

1

Recent Filings

6

Address

C/O NOVOCURE INC., 20 VALLEY STREAM PKWY SUITE 300

MALVERN, PA, 19355

View on SEC.gov